The Movement of Multidrug-Resistant Tuberculosis across Borders in East Africa Needs a Regional and Global Solution
article has not abstract
Vyšlo v časopise:
The Movement of Multidrug-Resistant Tuberculosis across Borders in East Africa Needs a Regional and Global Solution. PLoS Med 12(2): e32767. doi:10.1371/journal.pmed.1001791
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001791
Souhrn
article has not abstract
Zdroje
1. World Health Organization (2013) Global Tuberculosis Report 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf. Accessed 16 January 2015. Geneva, Switzerland.
2. (1986) Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study. Tubercle 67: 5–15. 3521015
3. Fox W, Ellard GA, Mitchison DA (1999) Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis 3: S231–279. 10529902
4. Mitchison DA (1998) How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 2: 10–15. 9562106
5. World Health Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf. Accessed 16 January 2015. Geneva, Switzerland: World Health Organization.
6. World Health Organization (2014) Global Tuberculosis Report 2014. http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf. Accessed 16 January 2015. Geneva, Switzerland.
7. Pietersen E, Ignatius E, Streicher EM, Mastrapa B, Padanilam X, et al. (2014) Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet 383: 1230–1239. doi: 10.1016/S0140-6736(13)62675-6 24439237
8. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al. (2010) HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 181: 80–86. doi: 10.1164/rccm.200907-0989OC 19833824
9. UNHCR (2013) 2013 UNHCR Global Report—Kenya. http://www.unhcr.org/539809efb.html. Accessed 16 January 2015.
10. The Global Fund to Fight AIDS, Tuberculosis, and Malaria, (2014) Somalia. http://portfolio.theglobalfund.org/en/Country/Index/SOM. Accessed 16 January 2015. Geneva, Switzerland.
11. Sindani I, Fitzpatrick C, Falzon D, Suleiman B, Arube P, et al. (2013) Multidrug-resistant tuberculosis, Somalia, 2010–2011. Emerg Infect Dis 19: 478–480. doi: 10.3201/eid1903.121287 23621911
12. Regional Mixed Migration Secretariat (2014) Mixed Migration in Horn of Africa and Yemen. http://www.regionalmms.org/fileadmin/content/rmms_dashboard_map/November_2014_RMMS_Monthly_Map_.pdf. Accessed 16 January 2015. Nairobi, Kenya.
13. CDC (2005) Multidrug-resistant tuberculosis in Hmong refugees resettling from Thailand into the United States, 2004–2005. MMWR Morb Mortal Wkly Rep 54: 741–744. 16079738
14. Marras TK, Wilson J, Wang EE, Avendano M, Yang JW (2003) Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000. Chest 124: 915–921. 12970017
15. Truong DH, Hedemark LL, Mickman JK, Mosher LB, Dietrich SE, et al. (1997) Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992–1995. JAMA 277: 735–738. 9042846
16. Oeltmann JE, Varma JK, Ortega L, Liu Y, O'Rourke T, et al. (2008) Multidrug-resistant tuberculosis outbreak among US-bound Hmong refugees, Thailand, 2005. Emerg Infect Dis 14: 1715–1721. doi: 10.3201/eid1411.071629 18976554
17. Githui WA, Hawken MP, Juma ES, Godfrey-Faussett P, Swai OB, et al. (2000) Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis 4: 947–955. 11055762
18. Hemhongsa P, Tasaneeyapan T, Swaddiwudhipong W, Danyuttapolchai J, Pisuttakoon K, et al. (2008) TB, HIV-associated TB and multidrug-resistant TB on Thailand's border with Myanmar, 2006–2007. Trop Med Int Health 13: 1288–1296. doi: 10.1111/j.1365-3156.2008.02139.x 18721186
19. Salvo F, Dorjee K, Dierberg K, Cronin W, Sadutshang TD, et al. (2014) Survey of tuberculosis drug resistance among Tibetan refugees in India. Int J Tuberc Lung Dis 18: 655–662. doi: 10.5588/ijtld.13.0516 24903934
20. Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, et al. (2014) Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 18: 1019–1025. doi: 10.5588/ijtld.13.0834 25189547
21. World Health Organization (2014) Drug Resistant TB Surveillance & Response Supplement: Global Tuberculosis Report 2014. http://www.who.int/tb/publications/global_report/gtbr14_supplement_web_v3.pdf. Accessed 16 January 2015. World Health Organization. WHO/HQ/TB/2014.12 WHO/HQ/TB/2014.12.
22. Coninx R (2007) Tuberculosis in complex emergencies. Bull World Health Organ 85: 637–640. 17768523
23. Kimbrough W, Saliba V, Dahab M, Haskew C, Checchi F (2012) The burden of tuberculosis in crisis-affected populations: a systematic review. Lancet Infect Dis 12: 950–965. doi: 10.1016/S1473-3099(12)70225-6 23174381
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2015 Číslo 2
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
- The Movement of Multidrug-Resistant Tuberculosis across Borders in East Africa Needs a Regional and Global Solution
- Enabling Dynamic Partnerships through Joint Degrees between Low- and High-Income Countries for Capacity Development in Global Health Research: Experience from the Karolinska Institutet/Makerere University Partnership
- The Role of Alleles in Susceptibility to Haloperidol-Induced Toxicity in Mice and Humans